BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 21, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Nov. 15, 2013
View Archived Issues
Svelte enrolls final patient in DIRECT II clinical study
Svelte Medical Systems (New Providence, New Jersey) reported the enrollment of the final patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) clinical study.
Read More
Chinese orthopedic company initiates IPO in Hong Kong
Read More
International report: AirXpanders gets Australian approval for its AeroForm
Read More
Washington roundup: FDA approves NeuroPace RNS for refractory epilepsy
Read More
Court report: J&J looking at $4 billion settlement regarding ASR
Read More
Financings roundup: Tandem Diabetes Care prices IPO at $15/share
Read More
Patent watch: Neovasc gets protection for Tiara valve prosthesis
Read More
Agreements/contracts: Visualant and IV to accelerate ChromaID tech applications
Read More
Deals roundup: PositiveID sells interest in VeriTeQ for $750,000
Read More
People in the News
Read More
Product Briefs
Read More
Med-Tech Notes
Read More
MDD's Diagnostic Extra
Read More
